Symptoms and other factors associated with time to diagnosis and stage of lung cancer: A prospective cohort study

British Journal of Cancer

Volumn 112, Issue , 2015, Pages S6-S13

  Walter, F M ^a,b   Rubin, G ^c   Bankhead, C ^d   Morris, H C ^a   Hall, N ^c   Mills, K ^a   Dobson, C ^c   Rintoul, R C ^e   Hamilton, W ^f   Emery, J ^a,b,g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c DURHAM UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e PAPWORTH HOSPITAL   (United Kingdom)

^f UNIVERSITY OF EXETER   (United Kingdom)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Diagnosis; Diagnostic interval; Early stage; Late stage; Lung cancer; Symptom

Indexed keywords

ADULT; AGED; CANCER STAGING; CARCINOMA; CHEST PAIN; COHORT ANALYSIS; COMPLICATION; COUGH; DELAYED DIAGNOSIS; DYSPNEA; FEMALE; HEMOPTYSIS; HUMAN; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SHOULDER PAIN; THORACIC NEOPLASMS; TIME; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEST PAIN; COHORT STUDIES; COUGH; DELAYED DIAGNOSIS; DYSPNEA; ENGLAND; FEMALE; HEMOPTYSIS; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; SHOULDER PAIN; THORACIC NEOPLASMS; TIME FACTORS;

EID: 84949215729     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.30     Document Type: Article

References (31)

1. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Brit J Cancer 101: S115–S124.
2. Ades AE, Biswas M, Welton NJ, Hamilton W (2014) Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis. Int J Epidemiology 43: 1865–1873.
3. Athey VL, Suckling RJ, Tod AM, Walters SJ, Rogers TK (2012) Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention. Thorax 67: 412–417.
4. Birt L, Hall N, Emery J, Banks J, Mills K, Johnson M, Hamilton W, Walter FM (2014) Responding to symptoms suggestive of lung cancer: a qualitative interview study. BMJ Open Respir Res 1: e000067.
5. Brindle L, Pope C, Corner J, Leydon G, Banerjee A (2012) Eliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study. BMJ Open 2: e001977.
6. Cancer Research UK (2014a) Lung cancer statistics. Available at http://info.cancerresearchuk.org/cancerstats/mortality/cancerdeaths/(last accessed October 2014).
7. Cancer Research UK (2014b) Lung cancer stage statistics. Available at http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/incidence/uk-lung-cancer-incidence-statistics#By6 (last accessed November 2014).
8. Cancer Research UK (2014c) Be Clear On Cancer. Available at http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/lung/(last accessed November 2014).
9. Corner J, Hopkinson J, Fitzsimmons D, Barclay S, Muers M (2005) Is late diagnosis of lung cancer inevitable? Interview study of patients’ recollections of symptoms before diagnosis. Thorax 60: 314–319.
10. Corner J, Hopkinson J, Roffe L (2006) Experience of health changes and reasons for delay in seeking care: a UK study of the months prior to the diagnosis of lung cancer. Soc Sci Med 62: 1381–1391.
11. Emery JD, Walter FM, Gray V, Sinclair C, Howting D, Bulsara M, Bulsara C, Webster A, Auret K, Saunders C, Nowak A, Holman CD (2013) Diagnosing cancer in the bush: a mixed-methods study of symptom appraisal and help-seeking behaviour in people with cancer from rural Western Australia. Fam Pract 30: 294–301.
12. Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlund M, Lockwood G, Tishelman C, Vedsted P, Vigmostad MN, Ramirez AJ, Wardle J. International Cancer Benchmarking Partnership Module 2 Working Group (2013) Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer 108: 292–300.
13. Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U (2013) Evaluation of risk assessment tools for suspected cancer in general practice: a cohort study. Br J Gen Pract 63: e30–e36.
14. Hamilton W, Peters TJ, Round A, Sharp D (2005) What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 60: 1059–1065.
15. Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Klint A, Peake M, Strand TE, Linklater K, Robinson D, Møller H (2010) National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 65: 436–441.
16. Index of Multiple Deprivation (2014) Available at http://data.gov.uk/dataset/index-of-multiple-deprivation (last accessed October 2014).
17. Keeble S, Abel GA, Saunders CL, McPhail S, Walter FM, Neal RD, Rubin GP, Lyratzopoulos G (2014) Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a national audit of cancer diagnosis in primary care. Int J Cancer 135: 1220–1228.
18. Lyratzopoulos G, Abel G, Barbiere JM, Brown CH, Rous BA, Greenberg DC (2012) Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006–2009. Br J Cancer 106: 1068–1075.
19. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP (2013) Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 108: 686–690.
20. McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M, Screaton N, Rintoul RC, Hands CJ, Lifford K, Whynes D, Kerr KM, Page R, Parmar M, Wald N, Weller D, Williamson PR, Myles J, Hansell DM, Duffy SW, Field JK (2014) The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 7: 362–371.
21. Mitchell ED, Rubin G, Macleod U (2013) Understanding diagnosis of lung cancer in primary care: qualitative synthesis of significant event audit reports. Br J Gen Pract 63: e37–e46.
22. Neal RD, Din NU, Hamilton W, Ukoumunne O, Carter B, Stapley S, Rubin G (2014a) Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer 110: 584–592.
23. Neal RD, Nafees S, Pasterfield D, Hood K, Hendry M, Gollins S, Makin M, Stuart N, Turner J, Carter B, Wilkinson C, Williams N, Robling M (2014b) Patient-reported measurement of time to diagnosis in cancer: development of the Cancer Symptom Interval Measure (C-SIM) and randomised controlled trial of method of delivery. BMC. Health Serv Res 14: 3.
24. National Institute for Health and Care Excellence (2005) Referral guidelines for suspected cancer (CG 27). Available at http://www.nice.org.uk/CG027 (last accessed October 2014).
25. Rubin G, Walter F, Emery J, Neal R, Hamilton W, Wardle J (2014) Research into practice: prompt diagnosis of cancer in primary care. Br J Gen Pract 64: 428–430.
26. Shim J, Brindle L, Simon M, George S (2014) A systematic review of symptomatic diagnosis of lung cancer. Fam Pract 31: 137–148.
27. Smith S, Fielding S, Murchie P, Johnston M, Wyke S, Powell R, Devereux G, Nicolson M, Macleod U, Wilson P, Ritchie L, Lee AJ, Campbell NC (2013) Reducing the time before consulting with symptoms of lung cancer: a randomised controlled trial in primary care. Br J Gen Pract 63: e47–e54.
28. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D (2011) The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thoracic Oncol 6: 244–285.
29. Tørring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P (2012) Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 65: 669–678.
30. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P (2013) Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 49: 2187–2198.
31. Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD (2012) The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 106: 1262–1267.